喘和COPD药理学的当前和未来发展:ERS研讨会,那不勒斯2022年
Daiana Stolz1,2, Maria Gabriella Matera3, Paola Rogliani4
1Clinic of Pulmonary Medicine, Department of Internal Medicine, Medical Center University of Freiburg, Freiburg, Germany.
Breathe (Sheffield, England)
|June 28, 2023
概括
了解呼吸道药物机制的进展有助于喘和COPD的治疗. 未来的研究将专注于新药标,药物基因组学和生物类似药,以获得更好的患者结果.
科学领域:
- 肺病学和药理学 肺病学和药理学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 像喘和COPD这样的气道阻塞性疾病需要不断发展的药理管理.
- 了解疾病机制和药物通路的近期进展为治疗提供了新的途径.
研究的目的:
- 讨论关于喘和COPD药物的当前和未来发展.
- 探索药物作用机制,类固醇耐药性,并发病症和药物相互作用.
- 确定预后/治疗生物标志物和用于组织重塑和再生的新药点.
主要方法:
- 内容是基于欧洲呼吸学会研究研讨会的讨论.
- 关键话题包括药物基因组学,新兴生物类似药和监管方面.
主要成果:
- 了解药物机制对于临床转化和研究设计至关重要.
- 重点领域包括类固醇耐药性,并发症,药物相互作用和生物标志物.
- 正在探索组织重塑和再生的新目标.
结论:
- 对药物机制,药物基因组学和生物类似药的持续研究对于推进呼吸系统疾病治疗至关重要.
- 将体外发现转化为临床实践仍然是一个挑战,但对于患者的好处至关重要.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255
Asthma: Pathogenesis and Management
458
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
458
Drugs Used in Lower Respiratory Disorders: Overview
504
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
504
Antiasthma Drugs: β2-Adrenoceptor Agonists
317
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
317
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
312
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
312


